Life Sciences Tools and Services

Runda Medical

Runda Medical released FY2025 earnings on April 28 After-Market (BJT), actual revenue CNY 6.999 B (forecast CNY 7.72 B), actual EPS CNY -0.91 (forecast CNY -0.01)

Runda Medical released FY2025 Q4 earnings on April 28 After-Market (BJT), actual revenue CNY 1.73 B, actual EPS CNY -0.6398

Runda Medical released FY2026 Q1 earnings on April 28 After-Market (BJT), actual revenue CNY 1.511 B, actual EPS CNY -0.09

Runda Medical to Release FY2026 Q1 Earnings on April 29 After-Market (BJT)

Runda Medical to Release FY2025 Earnings on April 29 After-Market (BJT), Forecast Revenue CNY 7.72 B, EPS CNY -0.01

Runda Medical released FY2025 Q3 earnings on October 29 During-Market BJT, actual revenue CNY 1.798 B, actual EPS CNY -0.0699

Runda Medical released FY2025 9 Months Earnings on October 29 During-Market (BJT), actual revenue CNY 5.268 B, actual EPS CNY -0.269

Runda Medical to Release FY2025 Q3 Earnings Report on October 30 During-Market BJT

Runda Medical released FY2025 Q2 earnings on August 26 After-Market (BJT), actual revenue CNY 1.809 B, actual EPS CNY -0.089

Runda Medical released FY2025 Semi-Annual Earnings on August 26 After-Market (BJT), actual revenue CNY 3.47 B, actual EPS CNY -0.2

Runda Medical to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

Runda Medical Expected to Report a Loss of $109 to $130 Million in H1 2025

Ruanda Medical Holds Earnings Briefing

Afternoon Surge in Smart Healthcare Sector

Runda Medical reports net loss of 69.26 million yuan in Q1 2025

Runda Medical released FY2024 Q4 earnings on April 25 After-Market (BJT), actual revenue CNY 2.135 B, actual EPS CNY 0.0085

Runda Medical released FY2025 Q1 earnings on April 25 Pre-Market (BJT), actual revenue CNY 1.662 B, actual EPS CNY -0.11

Runda Medical released FY2024 earnings on April 25 After-Market (BJT), actual revenue CNY 8.312 B (forecast CNY 8.36 B), actual EPS CNY 0.09 (forecast CNY 0.385)

Runda Medical FY2025 Q1 Earnings Release Scheduled for April 26, Pre-Market BJT

Runda Medical to Release FY2024 Earnings on April 26 After-Market (BJT), Forecast Revenue CNY 8.36 B, EPS CNY 0.385

603108

Runda Medical announced that some shares held by shareholders Liu Hui and Zhu Wenyi have been judicially frozen by the Shanghai First Intermediate People's Court. Liu Hui holds 31,528,771 shares, of which 18,994,771 shares are frozen, totaling 21,898,771 shares frozen; Zhu Wenyi holds 31,518,408 shares, with 1,189,056 shares frozen, totaling 1,189,056 shares frozen. The two together hold 63,047,179 shares, with 23,087,827 shares frozen. This matter does not affect the change of actual controller and the company's operations

Zhitong

Runda Medical: Shareholders Liu Hui and Zhu Wenyi's partial shares have been judicially frozen

According to the Zhitong Finance APP, Runda Medical announced that its shareholders Zhu Wenyi and Liu Hui plan to reduce their holdings through block trades or centralized bidding within three months after the announcement date, with a total reduction not exceeding 2.99% of the company's shares

Runda Medical shareholders plan to reduce their holdings by no more than 2.99%

Runda Medical announced that due to meeting the redemption conditions, the company has decided not to redeem the "Runda Convertible Bonds" in advance. This bond will trigger the redemption clause if there are at least fifteen trading days with a closing price not lower than 130% of the conversion price during the trading days from August 25 to September 17, 2025. The board of directors stated that if the conditions are triggered again within the next three months, the redemption rights will also not be exercised. This convertible bond was listed in 2020, and the current conversion price is RMB 12.97 per share

Runda Medical: Triggered redemption clause, decided not to redeem "Runda Convertible Bonds" in advance for the time being

Runda Medical announced that its operating revenue in the first half of 2025 was 3.47 billion yuan, a year-on-year decrease of 16.08%. The net profit attributable to shareholders of the listed company was -121 million yuan, compared to 91.3061 million yuan in the same period last year

Runda Medical: Net loss of 121 million yuan in the first half of 2025

Runda Medical and Beijing Shijitan Hospital jointly released the "Shiyi" medical large model on August 12. This model simulates clinical doctors' thinking through an intelligent pre-consultation application, helping patients accurately describe their conditions and generate standardized medical records. The application has flexible adaptability, supporting differentiated consultations for first-time and follow-up patients, providing four modes: "specialty, expert, specific disease, and general," significantly improving patient consultation efficiency and experience

Runda Medical collaborates with Beijing Shijitan Hospital to launch the "Shiyi" medical large model

On August 12th, Runda Medical stated on the interactive platform that the company is currently not involved in brain-computer interface related technologies

Runda Medical: The company is currently not involved in brain-machine interface related technologies

Runda Medical announced that it expects to achieve a net profit attributable to the owners of the parent company of -130 million to -109 million yuan for the first half of 2025, indicating a loss compared to the same period last year. It is expected that the net profit attributable to the owners of the parent company, excluding non-recurring gains and losses, will be -145 million to -121 million yuan for the first half of 2025

Runda Medical: Expected net loss of 130 million to 109 million yuan in the first half of 2025

According to the Qichacha APP, recently, Fuyang Huizhong Medical Technology Co., Ltd. was established, with Zhang Jiantao as the legal representative. The business scope includes research and development of biochemicals; non-residential real estate leasing; sales of electrical instruments and meters; sales of instruments and meters, etc. Qichacha's equity penetration shows that the company is wholly owned by Runda Medical indirectly

Runda Medical established a new company engaged in the research and development of biochemistry product technologies

600568

301159

688561

600588

36Kr learned that as of the time of publication, the medical information sector weakened, with ST ZZYL hitting the limit down, and Yonyou, Qi An Xin-U, Hongjing Technology, Runda Medical, SunwayWorld, and Weining Health also following the decline

36Kr

ZZYL

SunwayWorld

Qi An Xin

Yonyou

GloryView

Winning Health

The medical information sector weakened, and ST ZZYL hit the limit down

According to the Qichacha APP, recently, Fuyang Runda Medical Technology Co., Ltd. was established, with Lin Chao as the legal representative. The business scope includes: production of Class III medical devices; operation of Class III medical devices; medical services; internet information services for medical devices, etc. Qichacha's equity penetration shows that the company is jointly held by Runda Medical and others

Runda Medical participates in the establishment of a new company, including internet information business for medical devices

Runda Medical(603108.SH)